Sato Pharmaceutical Co., Ltd recalls INON ACE Antacid tablets
- Recalling company
- Sato Pharmaceutical Co., Ltd
- Product
- INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and simethicone), 75-count bottle, Manufactured by: Sato Pharmaceutical Co., Ltd., NDC 49873-402-01
- Reason
- Failed Disintegration Specifications: above the time expected.
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Dec 19, 2025
- Reported
- Feb 4, 2026
- Distribution
- CA and HI
- Status
- Ongoing
- Quantity
- 3,640 bottles
- Lot / codes
- Lot#: PWXT, Exp 1/31/2027
- Company location
- Tokyo, N/A
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0298-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0298-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.